BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anlon Healthcare Ltd IPO is open
Apply for the Anlon Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

506919

MAKERSL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MAKERS LABORATORIES LTD. Share Price Update

As of the latest trading session, MAKERS LABORATORIES LTD. share price is currently at ₹ 147.95, which is up by ₹ 0.89 from its previous closing. Today, the stock has fluctuated between ₹ 145.15 and ₹ 149.45. Over the past year, MAKERS LABORATORIES LTD. has achieved a return of -13.27 %. In the last month alone, the return has been -0.03 %. Read More...

Investment Returns

Over 1 Month -0.03% Over 3 Months 0.61% Over 6 Months 3.70% Over 1 Year -13.27%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MAKERS LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    86.80

  • P/E Ratio (TTM)

    15.53

  • Beta

    0.42

  • Book Value / share

    95.03

  • Return on equity

    -9.63%

  • EPS (TTM)

    9.47

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.27

info icon alternate text

MAKERS LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 13.73
Operating Expense 14.06
Net Profit -0.27
Net Profit Margin (%) -1.96
Earnings Per Share (EPS) -0.46
EBITDA 0.50
Effective Tax Rate (%) 10.00
Particulars MAR 2025 (Values in Cr)
Revenue 9.70
Operating Expense 11.69
Net Profit -1.40
Net Profit Margin (%) -14.43
Earnings Per Share (EPS) -2.38
EBITDA -1.19
Effective Tax Rate (%) 28.93
Particulars DEC 2024 (Values in Cr)
Revenue 9.45
Operating Expense 10.87
Net Profit -0.77
Net Profit Margin (%) -8.14
Earnings Per Share (EPS) -1.31
EBITDA 0.01
Effective Tax Rate (%) 9.41
Particulars SEP 2024 (Values in Cr)
Revenue 11.50
Operating Expense 12.71
Net Profit 8.03
Net Profit Margin (%) 69.82
Earnings Per Share (EPS) 13.62
EBITDA 10.02
Effective Tax Rate (%) 10.57
Particulars JUN 2024 (Values in Cr)
Revenue 12.29
Operating Expense 13.66
Net Profit -1.22
Net Profit Margin (%) -9.92
Earnings Per Share (EPS) -2.07
EBITDA -0.14
Effective Tax Rate (%) 1.61
Particulars MAR 2025 (Values in Cr)
Revenue 42.94
Operating Expense 48.94
Net Profit 4.64
Net Profit Margin (%) 10.80
Earnings Per Share (EPS) 7.87
EBITDA 8.71
Effective Tax Rate (%) 5.88
Particulars MAR 2024 (Values in Cr)
Revenue 49.09
Operating Expense 57.19
Net Profit -6.95
Net Profit Margin (%) -14.15
Earnings Per Share (EPS) -11.78
EBITDA -2.62
Effective Tax Rate (%) 0.14
Particulars MAR 2023 (Values in Cr)
Revenue 42.55
Operating Expense 50.46
Net Profit -6.36
Net Profit Margin (%) -14.94
Earnings Per Share (EPS) -10.58
EBITDA -3.00
Effective Tax Rate (%) 6.04
Particulars MAR 2022 (Values in Cr)
Revenue 52.38
Operating Expense 52.92
Net Profit 0.17
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.35
EBITDA 3.90
Effective Tax Rate (%) 45.16
Particulars MAR 2021 (Values in Cr)
Revenue 44.41
Operating Expense 46.90
Net Profit -1.62
Net Profit Margin (%) -3.64
Earnings Per Share (EPS) -3.29
EBITDA 3.72
Effective Tax Rate (%) 22.22
Particulars MAR 2025 (Values in Cr)
Book Value / Share 119.49
ROE % 4.90
ROCE % 6.43
Total Debt to Total Equity 0.22
EBITDA Margin 8.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.85
ROE % -7.27
ROCE % -2.19
Total Debt to Total Equity 0.29
EBITDA Margin 2.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 117.28
ROE % -3.40
ROCE % 1.60
Total Debt to Total Equity 0.31
EBITDA Margin 5.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 121.17
ROE % 20.61
ROCE % 22.06
Total Debt to Total Equity 0.38
EBITDA Margin 16.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 110.08
ROE % 2.49
ROCE % 5.96
Total Debt to Total Equity 0.38
EBITDA Margin 13.23
Particulars MAR 2025 (Values in Cr)
Book Value / Share 95.04
ROE % -9.63
ROCE % -6.71
Total Debt to Total Equity 0.16
EBITDA Margin -3.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 87.19
ROE % -12.67
ROCE % -7.69
Total Debt to Total Equity 0.24
EBITDA Margin -5.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 98.78
ROE % -11.71
ROCE % -7.67
Total Debt to Total Equity 0.28
EBITDA Margin -7.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 102.30
ROE % 0.42
ROCE % 3.01
Total Debt to Total Equity 0.35
EBITDA Margin 7.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.92
ROE % -3.44
ROCE % -0.78
Total Debt to Total Equity 0.31
EBITDA Margin 8.38
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 147.94
Total Liabilities 147.94
Total Equity 115.19
Share Outstanding 5900376
Price to Book Ratio 1.36
Return on Assets (%) 5.06
Return on Capital (%) 6.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.23
Total Assets 161.25
Total Liabilities 161.25
Total Equity 104.33
Share Outstanding 5900376
Price to Book Ratio 1.29
Return on Assets (%) -3.88
Return on Capital (%) -5.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.36
Total Assets 152.29
Total Liabilities 152.29
Total Equity 109.67
Share Outstanding 5900376
Price to Book Ratio 0.99
Return on Assets (%) -3.11
Return on Capital (%) -3.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.67
Total Assets 144.33
Total Liabilities 144.33
Total Equity 98.09
Share Outstanding 4916980
Price to Book Ratio 1.78
Return on Assets (%) 3.44
Return on Capital (%) 4.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.21
Total Assets 136.19
Total Liabilities 136.19
Total Equity 86.57
Share Outstanding 4916980
Price to Book Ratio 2.37
Return on Assets (%) -0.24
Return on Capital (%) -0.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 71.39
Total Liabilities 71.39
Total Equity 56.07
Share Outstanding 5900376
Price to Book Ratio 1.36
Return on Assets (%) 6.50
Return on Capital (%) 8.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 86.14
Total Liabilities 86.14
Total Equity 51.44
Share Outstanding 5900376
Price to Book Ratio 1.29
Return on Assets (%) -8.06
Return on Capital (%) -10.69
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 84.79
Total Liabilities 84.79
Total Equity 58.28
Share Outstanding 5900376
Price to Book Ratio 0.99
Return on Assets (%) -7.50
Return on Capital (%) -9.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 85.48
Total Liabilities 85.48
Total Equity 50.30
Share Outstanding 4916980
Price to Book Ratio 1.78
Return on Assets (%) 0.20
Return on Capital (%) 0.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.34
Total Assets 79.11
Total Liabilities 79.11
Total Equity 49.62
Share Outstanding 4916980
Price to Book Ratio 2.37
Return on Assets (%) -2.04
Return on Capital (%) -2.55
Particulars MAR 2025 (Values in Cr)
Net Income 13.41
Cash from Operations -1.67
Cash from Investing 19.74
Cash from Financing -15.83
Net change in Cash -0.17
Free Cash Flow 2.26
Particulars MAR 2024 (Values in Cr)
Net Income -3.91
Cash from Operations 2.61
Cash from Investing -6.88
Cash from Financing 5.73
Net change in Cash -0.30
Free Cash Flow 9.23
Particulars MAR 2023 (Values in Cr)
Net Income -0.83
Cash from Operations -6.15
Cash from Investing 1.25
Cash from Financing 5.78
Net change in Cash -1.58
Free Cash Flow 6.75
Particulars MAR 2022 (Values in Cr)
Net Income 15.68
Cash from Operations 24.13
Cash from Investing -21.79
Cash from Financing 0.32
Net change in Cash -2.96
Free Cash Flow 34.01
Particulars MAR 2025 (Values in Cr)
Net Income 4.92
Cash from Operations -1.14
Cash from Investing 16.13
Cash from Financing -14.55
Net change in Cash 0.00
Free Cash Flow 1.27
Particulars MAR 2024 (Values in Cr)
Net Income -6.95
Cash from Operations -2.74
Cash from Investing -2.03
Cash from Financing 5.11
Net change in Cash 0.01
Free Cash Flow -0.04
Particulars MAR 2023 (Values in Cr)
Net Income -6.77
Cash from Operations -1.02
Cash from Investing -3.55
Cash from Financing 4.93
Net change in Cash -0.03
Free Cash Flow 3.45
Particulars MAR 2022 (Values in Cr)
Net Income 0.31
Cash from Operations 7.35
Cash from Investing -8.78
Cash from Financing 1.76
Net change in Cash -0.20
Free Cash Flow 18.44
Particulars MAR 2021 (Values in Cr)
Net Income -2.07
Cash from Operations 2.04
Cash from Investing -2.64
Cash from Financing 1.37
Net change in Cash -0.61
Free Cash Flow 3.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.62 13.31 1.78 249.98 30.00 / 69.75
BLISS GVS PHARMA LTD 162.50 16.07 1.63 1714.33 105.05 / 190.65
CIPLA LTD 1579.85 23.66 4.09 127613.03 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 327.35 9.22 2.65 963.42 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.62 17.73 5.15 249.98 30.00 / 69.75
AMRUTANJAN HEALTH CARE LTD. 703.70 37.31 6.22 2034.44 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8014.90 94.75 26.01 20037.25 6222.35 / 10653.05
BLISS GVS PHARMA LTD 162.50 24.29 1.61 1714.33 105.05 / 190.65

MAKERS LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
147.10 0.03 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 147.30
  • 26 Days 149.60
  • 10 Days 148.20
  • 50 Days 150.20
  • 12 Days 148.50
  • 100 Days 150.80
  • 20 Days 149.20
  • 200 Days 150.70
147.37 PIVOT

First Support

144.78

First Resistance

149.63

Second Support

142.52

Second Resistance

152.22

Third Support

139.93

Third Resistance

154.48

RSI

46.20

ADX

23.88

MACD

-1.12

Williams % R

-84.55

Commodity Channel Index (CCI)

-83.52

Date

2025-08-26

Week

1121.00

Same Day

906.00

Month

1510.00

1 Year

0.43

3 Year

0.30

Over 1 Month

-0.03%

down

Over 1 Year

-13.27%

down

Over 3 Months

0.61%

down

Over 3 Years

-0.79%

down

Over 6 Months

3.70%

down

Over 5 Years

10.38%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

MAKERS LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

MAKERS LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
01 Aug 2019 1.0 Final 03 Aug 2019 Equity shares
26 Jul 2018 1.0 Final 28 Jul 2018 Equity shares
20 Jul 2017 1.0 Final 22 Jul 2017 Equity shares
02 Aug 2016 1.0 Final 04 Aug 2016 Equity shares
28 Jul 2015 1.0 Final 30 Jul 2015 Equity shares
29 Jul 2011 1.0 Final 02 Aug 2011 Equity shares
17 Aug 2010 1.0 Final 19 Aug 2010 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MAKERS LABORATORIES LTD. Share Price

Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates.

Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL.

During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.

MLL has gone for expansion in the year 1999. It has increased the installed capacity of Tablets & Capsules by 13.25 crores(Nos) and the company has again expanded the installed capacity of Tablets & Capsules in the year 2000 by 15.00 crores(Nos),taking the total capacity to 60.00 crores.

The Modernisation of Formulation Drugs which was undertaken during 1999-2000 was completed successfully and this project was financed through Rights Issue of Equity Shares.

The Palghar Plant Liquid Department was upgraded under the standard of schedule 'M' during 2004. The Company sold its unviable formulations manufacturing unit at Palghar, in Thane Dist. during 2008. Harleystreet Pharmaceuticals Ltd. was merged with the Company by a Scheme of Amalgamation during the period 2011. In terms of the said Scheme of Amalgamation, 571,440 Equity shares of the Company of Rs 10/- each fully paid up were issued to the shareholders of HPL in the ratio of 6 fully paid up equity shares of Rs. 10/- each of the Company for every 10 fully paid up equity shares of Rs. 10/- each of HPL. i.e., 6:10.

The Company sold its bulk drugs manufacturing unit at Dombivili, in Thane Dist. during the year 2016-17. It launched a new range of Diabetic & Hypertensive drugs including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), Hypernorm range (Telmisartan).

The Company further acquired 52,50,000 Equity shares of Rs 10/- each of Resonance Specialties Limited and became its subsidiary effective from 11th December, 2020. During 2020-21, the Company started manufacturing new ophthalmic eye drops at Naroda, in Ahmedabad in February, 2021. It started work on upgradation / modernization/capacity enhancement of its old liquid injectable manufacturing unit at Naroda, Gujarat in January, 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 1984
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Makers Laboratories Ltd?

Answer Field

Makers Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 147.10 as on Aug 28 2025 03:24 PM.

What is the Market Cap of Makers Laboratories Ltd Share?

Answer Field

The market cap of Makers Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 86.80 as on Aug 28 2025 03:24 PM.

What is the 52 Week High and Low of Makers Laboratories Ltd?

Answer Field

The 52 Week High and Low of Makers Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 230.00 and ₹ 122.00.

What is 1 year return for Makers Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -13.27%.

What is the P/E Ratio of Makers Laboratories Ltd Share?

Answer Field

As on Aug 28 2025 03:24 PM the price-to-earnings (PE) ratio for Makers Laboratories Ltd share is 15.53.

What is the PB ratio of Makers Laboratories Ltd Share?

Answer Field

As on Aug 28 2025 03:24 PM, the price-to-book (PB) ratio for Makers Laboratories Ltd share is 95.03.

How to Buy Makers Laboratories Ltd Share?

Answer Field

You can trade in Makers Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Makers Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Makers Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Makers Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91